In human bladder cancer cells, genistein suppresses production or release of angiogenic proteins of PDGF-A, tissue factor (TF), and VEGF165, as well as enzymes involved in matrix degradation for MMP-2, MMP-9, and uPA. Here, MMP9 is linked to urinary bladder cancer.